Insulin use is associated with poor limb salvage and survival in diabetic patients with chronic limb ischemia

Journal of Vascular Surgery

Volumn 51, Issue 5, 2010, Pages 1178-1189

  Dosluoglu, Hasan H ^a,b   Lall, Purandath ^a,b   Nader, Nader D ^a,b   Harris, Linda M ^b   Dryjski, MacIej L ^b  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ADULT; AGED; AMPUTATION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GANGRENE; HUMAN; HYPERTENSION; KIDNEY FAILURE; LIMB ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; REVASCULARIZATION; SURVIVAL; SURVIVAL RATE; TREATMENT INDICATION; CASE CONTROL STUDY; CHRONIC DISEASE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR DISEASE; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT OUTCOME; VASCULARIZATION;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHRONIC DISEASE; CONFIDENCE INTERVALS; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTERMITTENT CLAUDICATION; ISCHEMIA; LIMB SALVAGE; LOWER EXTREMITY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL VASCULAR DISEASES; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77952318040     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.11.077     Document Type: Article

References (37)

1. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 2006;29:2114-6.
2. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;10; 110:738-43.
3. Nasr MK, McCarthy RJ, Hardman J, Chalmers A, Horrocks M. The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischemia. Eur J Vasc Endovasc Surg 2002; 23:398-403.
4. Faglia E, Dalla Paola L, Clerici G, Clerissi J, Graziani L, Fusaro M, et al. Peripheral angioplasty as the first choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg 2005;29:620-7.
5. BASIL Trial participants. Bypass versus angioplasty in severe ischemia of the leg (BASIL): multicentre, randomized controlled trial. Lancet 2005;366:1925-34.
6. Dosluoglu HH, O'Brien-Irr MS, Lukan J, Harris LM, Dryjski ML, Cherr GS. Does preferential use of endovascular interventions by vascular surgeons improve limb salvage, control of symptoms and survival in patients presenting with critical limb ischemia? Am J Surg 2006;192: 572-6.
7. Wolfe KD, Bruijnen H, Loeprecht H, Rumenapf G, Schweiger H, Grabitz K, et al. Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: results of a multi-centre comparative analysis. Eur J Vasc Endovasc Surg 2003;25: 229-34.
8. Panneton JM, Gloviczki P, Bower TC, Rhodes RM, Canton LG, Toomey BJ. Pedal bypass for limb salvage: impact of diabetes and long-term outcome. Ann Vasc Surg 2000;14:640-7.
9. Hertzer NR, Bena JF, Karafa MT. A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease. J Vasc Surg 2007;46:271-9.
10. Akbari CM, Pomposelli FB Jr, Gibbons GW, Campbell DR, Pulling MC, Mydlarz D, LoGerfo FW. Lower extremity revascularization in diabetes: late observations. Arch Surg 2000;135:452-6.
11. Bakken AM, Palchik E, Hart JP, Rhodes JM, Saad WE, Davies MG. Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions. J Vasc Surg 2007;46:946-58.
12. DeRubertis BG, Pierce M, Ryer EJ, Trocciola S, Kent KC, Faries PL. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg 2008;47:101-8.
13. Dick F, Diehm N, Galimanis A, Husmann M, Schmidli J, Baumgartner I. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg 2007;45:751-61.
14. Laxdal E, Jenssen GL, Pedersen G, Aune S. Subintimal angioplasty as a treatment of superficial femoral artery occlusions. Eur J Vasc Endovasc Surg 2003;25:578-82.
15. Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M. Primary patency of long-segment self-expanding nitinol stents in the femoro-popliteal arteries. J Endovasc Ther 2005;12:6-12.
16. Awad S, Karkos CD, Serrachino-Inglott F, Cooper NJ, Butterfield JS, Asleigh R, et al. The impact of diabetes on current revascularization practice and clinical outcome in patients with critical lower limb ischemia. Eur J Vasc Endovasc Surg 2006;32:51-9.
17. Danielsson G, Albrechtsson U, Norgren L, Danielsson P, Ribble E, Thorne J, et al. Percutaneous transluminal angioplasty of crural arteries: diabetes and other factors influencing outcome. Eur J Vasc Endovasc Surg 2001;21:432-6.
18. Black JH, La Muraglia GM, Kwolek CJ, Brewster DC, Watkins MT, Cambria RP. Contemporary results of angioplasty-based infrainguinal percutaneous interventions. J Vasc Surg 2005;42:932-9.
19. Boyne MS, Saudek CD. Effect of insulin therapy on macrovascular risk factors in type 2 diabetes. Diabetes Care 1999;22 (Suppl 3):C45-53.
20. Abraira C, Colwell J, Nuttall F, Sawin CT, Henderson W, Comstock JP, et al. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med 1999;157:181-8.
21. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, et al. Hyperinsulinemia as a predictor of coronary artery disease mortality in a healthy population. Diabetologia 1991;34:356-61.
22. Liu QZ, Knowler WC, Nelson RG, Saad MF, Charles MA, Liebow IM, et al. Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses. Diabetes 1992;41:1141-50.
23. Ahn SS, Rutherford RB, Becker GJ, Comerota AJ, Johnston KW, McClean GK, et al. Reporting standards for lower extremity arterial endovascular procedures. Society for Vascular Surgery/International Society for Cardiovascular Surgery. J Vasc Surg 1993;17:1103-7.
24. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. Trans Atlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296.
25. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45 (Suppl S):S5-67.
26. Conrad MF, Cambria RP, Stone DH, Brewster DC, Kwolek CJ, Watkins MT, et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg 2006;44:762-9.
27. Lazaris AM, Tsiamis AC, Fishwick G, Bolia A, Bell PR. Clinical outcome of primary infrainguinal subintimal angioplasty in diabetic patients with critical lower limb ischemia. J Endovasc Ther 2004;11:447-53.
28. Trocciola SM, Chaer R, Dayal R, Lin SC, Kumar N, Rhee J, et al. Comparison of results in endovascular interventions in infrainguinal lesions: claudication versus critical limb ischemia. Am Surg 2005;71: 474-9.
29. da Silva AF, Desgranges P, Holdsworth J, Harris PL, McCollum P, Jones SM, et al. The management and outcome of critical limb isch-aemia in diabetic patients: results of a national survey. Audit Committee of the Vascular Surgical Society of Great Britain and Ireland. Diabet Med 1996;13:726-8.
30. Luther M, Lepäntalo M. Femorotibial reconstructions for chronic critical leg ischaemia: influence on outcome by diabetes, gender and age. Eur J Vasc Endovasc Surg 1997;13:569-77.
31. Dandona P, Aljada A. Advances in diabetes for the millennium: diabetes and the endothelium. Med Gen Med 2004;6(3 Suppl):6.
32. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994;94: 1172-9.
33. Sydow K, Mondon CE, Cooke JP. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc Med 2005;10 (Suppl 1):S35-43.
34. Ding Y, Vaziri ND, Coulson R, Kamanna VS, Roh DD. Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. Am J Physiol Endocrinol Metab 2000;279: E11-7.
35. Dandona P, Mikhailidis DP, Jeremy JY. Prostacyclin release in vivo. Lancet 1983;1:823-4.
36. Kalogeropoulou K, Mortzos G, Migdalis I, Velentzas C, Mikhailidis DP, Georgiadis E, Cordopatis P. Carotid atherosclerosis in type 2 diabetes mellitus: potential role of endothelin-1, lipoperoxides, and prostacyclin. Angiology 2002;53:279-85.
37. Maca T, Schillinger M, Hamwi A, Mlekusch W, Sabeti S, Wagner O, Minar E. Insulin, C-peptide, and restenosis after femoral artery balloon angioplasty in type II diabetic and nondiabetic patients. J Vasc Interv Radiol 2005;16:31-5.